Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amgen USD 5.08B 14M 2023-12
BioCryst Pharmaceuticals USD 85.61M 4.06M 2023-09
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Daiichi Sankyo JPY 280.77B 23.61B 2023-09
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Gilead Sciences USD 5.5B 18M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
Ironwood Pharmaceuticals USD 117.13M 13.38M 2021-12
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
TG Therapeutics USD 36.12M 126.19M 2023-12
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



PTC Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.